Solvent removal from pharmaceuticals |
A shift towards healthier lifestyles has dramatically increased use of botanical based Nutraceuticals that are also finding their way into Pharmaceutical products. This includes functional extracts of herbs, vegetables, fruits and other plants.
The liquid extract may be used as is or further processed into a dry powder. As is well known, active ingredients contained in many Pharmaceutical products are prone to heat denaturation. To minimise thermal degradation and consequent loss of functionality the action of the spinning cones in the Centritherm evaporator reduce the contact time between the heating surface and the product to approximately 1 second heat contact time.
Centritherm evaporators are usually operated with an evaporation temperature of 50°C and a steam temperature of 120°C. However, due to the heat sensitive nature of some compounds, these conditions may be adjusted to reduce the temperature difference and further reduce the thermal impact. For example, lower operating temperatures, from 25°C, and steam temperatures of 70-90°C are currently used for manufacture of various enzymes and protein fractions.
The minimisation of loss and / or damage to the compounds of interest is critical for the finished product. Active ingredients are generally regarded as heat sensitive and, as such, the preservation of these compounds is of paramount importance during the concentration stage as heat is applied to evaporate the solvent.
Concentrates produced by the Centritherm evaporator are of extremely high quality as the thermal impact they experience during processing is negligible.
Key benefits of the Centritherm include:
Summary
|
Some of the products currently
Amylase
Glutamic Acid
Biological derivatives: Gland extract
|
| back | |